Paul Edward Kelly, COO of Relmada Therapeutics RLMD, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $198K. The latest trade was on 25/12/12.

PK

PK

Paul Edward Kelly

COO

Company

Relmada Therapeutics RLMD

First filing

23/05/30

Trades

9 trades

Buys / sales

3 / 0

12-month net buying

$198K

Last trade

25/12/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Relmada TherapeuticsRLMD	Open-market buy	25/11/05	25/11/06	90,000 sh	$2.20	$198,000	+21.8%
Relmada TherapeuticsRLMD	Open-market buy	25/05/16	25/05/20	200,000 sh	$0.43	$86,000	+94.2%
Relmada TherapeuticsRLMD	Open-market buy	24/09/09	24/09/11	25,000 sh	$2.59	$64,750	+13.3%